Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2007 May;6(3):237-40.
doi: 10.1016/j.jcf.2006.07.005. Epub 2006 Sep 12.

Use of continuous subcutaneous insulin infusion in patients with cystic fibrosis related diabetes: three case reports

Nicoletta Sulli  1 , Serenella Bertasi, Sabina Zullo, Blegina Shashaj
Affiliations
Free article
Case Reports

Use of continuous subcutaneous insulin infusion in patients with cystic fibrosis related diabetes: three case reports

Nicoletta Sulli et al. J Cyst Fibros. 2007 May.
Free article

Abstract

We used insulin pump therapy in three patients (two males and one female; age 5.5, 21 and 28.2 years, respectively) with CFRD and we reported the experience of 2 years of follow-up. In all the patients during the CSII treatment, the annual mean level of HbA1c reduced and the annual mean level of BMI increased, respected, the year before starting the CSII (in MDI treatment with 4 injections/day). The insulin requirements decreased during the CSII treatment and respected MDI treatment. During the CSII treatment, none of the patients exhibited episodes of DKA or severe hypoglycaemia. Only two episodes of lipohypertrophy and a slight local cutaneous inflammation were reported.

Conclusions: The use of CSII in our patients with CFRD improves the metabolic control of diabetes and the nutritional status with no concomitant problems related to this treatment.

PubMed Disclaimer

Publication types